AAN Issues Guidance on New Treatments for Early Alzheimer's Disease MINNEAPOLIS – New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease. To help neurologists discuss these therapies with patients and caregivers, the American Academy of Neurology has developed an Emerging Issues in Neurology article, published online on July 26, 2023, in Neurology ® , the medical journal of the American Academy of Neurology.

https://www.miragenews.com/aan-releases-new-treatment-guidelines-for-early-1054604/

#miragenews